ERIN DE LOS REYES

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PEACHTREE CITY, GA NPI 1174992192

General Payments — all program years on this page

$1,155.62

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $529.40 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $529.4020

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GENZYME CORPORATION $290.7910
Acerta Pharma LLC $139.796
Regeneron Healthcare Solutions, Inc. $56.712
GlaxoSmithKline, LLC. $42.112

By program year

Program yearAmountRecords
2021 $69.733
2022 $102.015
2023 $454.4821
2024 $529.4020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104399597 AstraZeneca Pharmaceuticals LP $28.29 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104624434 AstraZeneca Pharmaceuticals LP $10.25 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104658163 AstraZeneca Pharmaceuticals LP $27.23 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104786320 AstraZeneca Pharmaceuticals LP $18.65 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105458541 AstraZeneca Pharmaceuticals LP $27.51 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105547939 AstraZeneca Pharmaceuticals LP $27.86 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291445 Regeneron Healthcare Solutions, Inc. $31.92 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291447 Regeneron Healthcare Solutions, Inc. $24.79 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116455001 GlaxoSmithKline, LLC. $21.46 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116626150 GlaxoSmithKline, LLC. $20.65 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957611 GENZYME CORPORATION $24.35 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957629 GENZYME CORPORATION $13.18 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957633 GENZYME CORPORATION $37.83 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957639 GENZYME CORPORATION $45.14 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957643 GENZYME CORPORATION $42.94 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957663 GENZYME CORPORATION $6.92 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957665 GENZYME CORPORATION $28.97 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957667 GENZYME CORPORATION $45.18 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957677 GENZYME CORPORATION $10.43 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957679 GENZYME CORPORATION $35.85 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.